Compare AGCO Corporation (AGCO) vs Appian Corp (APPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AGCO Corporation vs Appian Corp — how do they compare? AGCO Corporation trades at $102.25 (market cap $7.10B), while Appian Corp trades at $35.5 (market cap $2.54B). The key difference: AGCO Corporation is far larger — about 2.8× Appian Corp's market cap, and AGCO Corporation pays a 1.18% dividend while Appian Corp pays none. Which is the better fit depends on your goals.
| AGCO | APPN | |
|---|---|---|
Market Cap | $7.10B | $2.54B |
Sector | Industrials | Technology |
52-Week High | $140.49 | $45.64 |
52-Week Low | $100.14 | $18.72 |
Enterprise Value | $9.37B | $2.67B |
Dividend Yield | 1.18% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AGCO Corporation
Agco is a global manufacturer of agricultural equipment. The company has five principal brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements by offering grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes over 3,200 dealer and distribution locations. Additionally, Agco offers both retail and wholesale financing to customers through its joint venture with Rabobank, a European food and agriculture focused bank.
Read more on AGCO →About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →
